Literature DB >> 10084629

Development of a standardized boating sobriety test.

A J McKnight1, J E Lange, A S McKnight.   

Abstract

A sobriety test capable of being administered on boats was developed as an aid in establishing probable cause to request a breath sample of recreational boat operators suspected of being over the legal alcohol limit. In a laboratory phase some 12 candidate measures suitable for use in a boating environment were assessed for their relationship to blood alcohol levels through administration to 32 subjects tested at blood alcohol concentrations (BACs) of 0.00, 0.06 and 0.12%. Four measures showing significant relationships to BAC were then administered by marine police to a sample of 60 recreational boaters found to have BACs ranging from 0.0 to 0.20%. Three measures still showing significant relationships to alcohol were horizontal gaze Nystagmus given in a seated position, reciting the alphabet from A to Z, and clapping hands alternately with palm and back of hand, while counting. Correlation of the measures with BAC, and the ability to distinguish boaters over and under a 0.10% limit were similar to those found over the same BAC range with the standardized field sobriety test (SFST) for motor vehicle operators. Where there is not sufficient cause to request a boat operator to proceed to shore for testing, a standardized boating sobriety test (SBST) making use of the three measures appears to be a suitable replacement for the SFST.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084629     DOI: 10.1016/s0001-4575(98)00056-6

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  2 in total

1.  Comparison of different methods assessing alcohol contribution to emergency room visits.

Authors:  Grażyna Swiątkiewicz; Jacek Moskalewicz; Cheryl J Cherpitel; Yu Ye
Journal:  Alkohol Narkom       Date:  2014

Review 2.  Review of the role of alcohol in drowning associated with recreational aquatic activity.

Authors:  T R Driscoll; J A Harrison; M Steenkamp
Journal:  Inj Prev       Date:  2004-04       Impact factor: 2.399

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.